Dorsey, E. R. et al. Global, regional, and nationwide burden of Parkinson’s disease, 1990–2016: A scientific evaluation for the Global Burden of Disease Study 2016. The Lancet Neurology 17, 939–953. https://doi.org/10.1016/S1474-4422(18)30295-3 (2018).Article
Google Scholar
Aarsland, D. et al. Parkinson disease-associated cognitive impairment. Nat. Rev. Dis. Primers. 7, 1–21. https://doi.org/10.1038/s41572-021-00280-3 (2021).Article
Google Scholar
Yarnall, A. J. et al. Characterizing gentle cognitive impairment in incident Parkinson disease: The ICICLE-PD Study. Neurology 82, 308–316. https://doi.org/10.1212/WNL.0000000000000066 (2014).Article
PubMed
PubMed Central
Google Scholar
Nicoletti, A. et al. Incidence of gentle cognitive impairment and dementia in Parkinson’s disease: The Parkinson’s disease cognitive impairment research. Front. Aging Neurosci. https://doi.org/10.3389/fnagi.2019.00021 (2019).Article
PubMed
PubMed Central
Google Scholar
Pigott, Ok. et al. Longitudinal research of regular cognition in Parkinson disease. Neurology 85, 1276–1282. https://doi.org/10.1212/WNL.0000000000002001 (2015).Article
CAS
PubMed
PubMed Central
Google Scholar
Kotagal, V., Spino, C., Bohnen, N. I., Koeppe, R. & Albin, R. L. Serotonin, β-amyloid, and cognition in Parkinson disease. Ann. Neurol. 83, 994–1002. https://doi.org/10.1002/ana.25236 (2018).Article
CAS
PubMed
PubMed Central
Google Scholar
van Laar, T., De Deyn, P. P., Aarsland, D., Barone, P. & Galvin, J. E. Effects of cholinesterase inhibitors in Parkinson’s disease dementia: A assessment of scientific knowledge. CNS Neurosci. Ther. 17, 428–441. https://doi.org/10.1111/j.1755-5949.2010.00166.x (2021).Article
CAS
Google Scholar
Leung, I. H. Ok. et al. Cognitive coaching in Parkinson disease: A scientific assessment and meta-analysis. Neurology 85, 1843–1851. https://doi.org/10.1212/WNL.0000000000002145 (2015).Article
PubMed
PubMed Central
Google Scholar
Dinkelbach, L., Brambilla, M., Manenti, R. & Brem, A. Ok. Non-invasive mind stimulation in Parkinson’s disease: Exploiting crossroads of cognition and temper. Neurosci. Biobehav. Rev. 75, 407–418. https://doi.org/10.1016/j.neubiorev.2017.01.021 (2017).Article
PubMed
Google Scholar
da Silva, F. C. et al. Effects of bodily train packages on cognitive perform in Parkinson’s disease sufferers: A scientific assessment of randomized managed trials of the final 10 years. PLoS ONE 13, e0193113. https://doi.org/10.1371/journal.pone.0193113 (2018).Article
CAS
PubMed
PubMed Central
Google Scholar
Litvan, I. et al. Diagnostic standards for gentle cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force tips: PD-MCI Diagnostic Criteria. Mov. Disord. 27, 3. https://doi.org/10.1002/mds.24893 (2012).Article
Google Scholar
Poewe, W. et al. Diagnosis and administration of Parkinson’s disease dementia. Int. J. Clin. Pract. 62, 1581–1587. https://doi.org/10.1111/j.1742-1241.2008.01869.x (2008).Article
CAS
PubMed
Google Scholar
Schulz, J., Pagano, G., Fernández Bonfante, J. A., Wilson, H. & Politis, M. Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson’s disease. Brain 141, 5. https://doi.org/10.1093/brain/awy072 (2018).Article
Google Scholar
Wilson, H. et al. Predict cognitive decline with scientific markers in Parkinson’s disease (PRECODE-1). J. Neural Transm. 127, 51–59. https://doi.org/10.1007/s00702-019-02125-6 (2020).Article
CAS
PubMed
Google Scholar
Shin, N.-Y. et al. Cortical thickness from MRI to foretell conversion from gentle cognitive impairment to dementia in Parkinson disease: A machine learning-based mannequin. Radiology 300, 203383. https://doi.org/10.1148/radiol.2021203383 (2021).Article
Google Scholar
Smith, N. et al. Predicting future cognitive impairment in de novo parkinson’s disease using scientific knowledge and structural MRI. Preprint at https://www.medrxiv.org/content/https://doi.org/10.1101/2021.08.13.21261662v1 (2021).Bäckström, D. et al. Prediction and early biomarkers of cognitive decline in Parkinson disease and atypical Parkinsonism: A population-based research. Brain Commun. 4, 2. https://doi.org/10.1093/braincomms/fcac040 (2022).Article
CAS
Google Scholar
Siderowf, A. et al. CSF amyloid β 1–42 predicts cognitive decline in Parkinson disease. Neurology 75, 1055–1061. https://doi.org/10.1212/WNL.0b013e3181f39a78 (2010).Article
CAS
PubMed
PubMed Central
Google Scholar
De Marchi, F., Carecchio, M., Cantello, R. & Comi, C. Predicting cognitive decline in Parkinson’s disease: Can we ask the genes?. Front. Neurol. 5, 224. https://doi.org/10.3389/fneur.2014.00224 (2014).Article
PubMed
PubMed Central
Google Scholar
Liu, G. et al. Prediction of cognition in Parkinson’s disease with a scientific–genetic rating: A longitudinal evaluation of 9 cohorts. The Lancet Neurology 16, 620–629. https://doi.org/10.1016/S1474-4422(17)30122-9 (2017).Article
PubMed
PubMed Central
Google Scholar
Hebling Vieira, B. et al. Predicting future cognitive decline from non-brain and multimodal mind imaging knowledge in wholesome and pathological growing old. Neurobiol. Aging 118, 55–65. https://doi.org/10.1016/j.neurobiolaging.2022.06.008 (2022).Article
CAS
PubMed
Google Scholar
Caspell-Garcia, C. et al. Multiple modality biomarker prediction of cognitive impairment in prospectively adopted de novo Parkinson disease. PLoS ONE 12, e0175674. https://doi.org/10.1371/journal.pone.0175674 (2017).Article
CAS
PubMed
PubMed Central
Google Scholar
Vercio, L. L. et al. Supervised machine studying instruments: A tutorial for clinicians. J. Neural Eng. 17, 062001. https://doi.org/10.1088/1741-2552/abbff2 (2020).Article
Google Scholar
MacEachern, S. J. & Forkert, N. D. Machine studying for precision drugs. Genome 64, 416–425. https://doi.org/10.1139/gen-2020-0131 (2021).Article
PubMed
Google Scholar
Geraedts, V. J. et al. Preoperative electroencephalography-based machine studying predicts cognitive deterioration after subthalamic deep mind stimulation. Mov. Disord. 36, 2324–2334. https://doi.org/10.1002/mds.28661 (2021).Article
PubMed
PubMed Central
Google Scholar
Kanekiyo, T., Xu, H. & Bu, G. ApoE and Aβ in Alzheimer’s disease: Accidental encounters or companions?. Neuron 81, 740–754. https://doi.org/10.1016/j.neuron.2014.01.045 (2014).Article
CAS
PubMed
PubMed Central
Google Scholar
Baek, M. S., Lee, N., Kim, J. W. & Hong, J. Y. Association of hippocampal subfield volumes with amyloid-beta deposition in Alzheimer’s disease. J. Clin. Med. 11(6), 1526. https://doi.org/10.3390/jcm11061526 (2022).Article
CAS
PubMed
PubMed Central
Google Scholar
Sturchio, A. et al. High cerebrospinal amyloid-β 42 is related to regular cognition in people with mind amyloidosis. EClinicalMedicine https://doi.org/10.1016/j.eclinm.2021.100988 (2021).Article
PubMed
PubMed Central
Google Scholar
Compta, Y. et al. Lewy- and Alzheimer-type pathologies in Parkinson’s disease dementia: Which is extra essential?. Brain 134, 1493–1505. https://doi.org/10.1093/brain/awr031 (2011).Article
PubMed
Google Scholar
Irwin, D. J., Lee, V.M.-Y. & Trojanowski, J. Q. Parkinson’s disease dementia: Convergence of α-synuclein, tau and amyloid-β pathologies. Nat. Rev. Neurosci. 14, 626–636. https://doi.org/10.1038/nrn3549 (2013).Article
CAS
PubMed
PubMed Central
Google Scholar
Maggi, G., Trojano, L., Barone, P. & Santangelo, G. Sleep problems and cognitive dysfunctions in Parkinson’s disease: A meta-analytic research. Neuropsychol. Rev. 31, 643–682. https://doi.org/10.1007/s11065-020-09473-1 (2021).Article
PubMed
Google Scholar
Cahn, D. A. et al. differential contributions of cognitive and motor element processes to bodily and instrumental actions of every day residing in Parkinson’s disease. Arch. Clin. Neuropsychol. 13(7), 575–583. https://doi.org/10.1093/arclin/13.7.575 (1998).Article
CAS
PubMed
Google Scholar
Pirogovsky, E. et al. Instrumental actions of every day residing are impaired in Parkinson’s disease sufferers with gentle cognitive impairment. Neuropsychology 28(2), 229–237. https://doi.org/10.1037/neu0000045 (2014).Article
PubMed
Google Scholar
Yousaf, T., Pagano, G., Niccolini, F. & Politis, M. Excessive daytime sleepiness could also be related to caudate denervation in Parkinson disease. J. Neurol. Sci. 387, 220–227. https://doi.org/10.1016/j.jns.2018.02.032 (2018).Article
PubMed
Google Scholar
Perez-Lloret, S. & Barrantes, F. J. Deficits in cholinergic neurotransmission and their scientific correlates in Parkinson’s disease. Npj Parkinson’s Dis. 2(1), 1–12. https://doi.org/10.1038/npjparkd.2016.1 (2016).Article
CAS
Google Scholar
Emre, M. et al. Rivastigmine for dementia related to Parkinson’s disease. N. Engl. J. Med. 351(24), 2509–2518. https://doi.org/10.1056/NEJMoa041470 (2004).Article
CAS
PubMed
Google Scholar
Aarsland, D., Marsh, L. & Schrag, A. Neuropsychiatric signs in Parkinson’s disease. Mov. Disord. 24(15), 2175–2186. https://doi.org/10.1002/mds.22589 (2009).Article
PubMed
PubMed Central
Google Scholar
Bäckman, L., Hill, R. D. & Forsell, Y. The affect of depressive symptomatology on episodic reminiscence functioning amongst clinically nondepressed older adults. J. Abnorm. Psychol. 105(1), 97–105. https://doi.org/10.1037//0021-843x.105.1.97 (1996).Article
PubMed
Google Scholar
Iqbal, Ok., Liu, F., Gong, C.-X. & Grundke-Iqbal, I. Tau in Alzheimer disease and associated Tauopathies. Curr. Alzheimer Res. 7, 656–664. https://doi.org/10.2174/156720510793611592 (2010).Article
CAS
PubMed
PubMed Central
Google Scholar
Liu, C. C., Kanekiyo, T., Xu, H. & Bu, G. Apolipoprotein E and Alzheimer disease: Risk, mechanisms, and remedy. Nat. Rev. Neurol. 9, 106–118. https://doi.org/10.1038/nrneurol.2012.263 (2013).Article
CAS
PubMed
PubMed Central
Google Scholar
Hampel, H. et al. The Amyloid-β pathway in Alzheimer’s disease. Mol. Psychiatry https://doi.org/10.1038/s41380-021-01249-0 (2021).Article
PubMed
PubMed Central
Google Scholar
Howlett, D. R. et al. Regional a number of pathology scores are related to cognitive decline in Lewy physique dementias. Brain Pathol. 25, 401–408. https://doi.org/10.1111/bpa.12182 (2014).Article
CAS
PubMed
PubMed Central
Google Scholar
Jellinger, Ok. A., Seppi, Ok., Wenning, G. Ok. & Poewe, W. Impact of coexistent Alzheimer pathology on the pure historical past of Parkinson’s disease. J. Neural Transm. 109, 329–339. https://doi.org/10.1007/s007020200027 (2002).Article
CAS
PubMed
Google Scholar
Jellinger, Ok. A. & Attems, J. Prevalence and affect of vascular and Alzheimer pathologies in Lewy physique disease. Acta Neuropathol. 115, 427–436. https://doi.org/10.1007/s00401-008-0347-5 (2008).Article
PubMed
Google Scholar
Cooley, S. A. et al. Longitudinal change in efficiency on the Montreal Cognitive Assessment in older adults. Clin. Neuropsychol. 29, 824–835. https://doi.org/10.1080/13854046.2015.1087596 (2015).Article
PubMed
PubMed Central
Google Scholar
Teipel, S. et al. Multimodal imaging in Alzheimer’s disease: Validity and usefulness for early detection. The Lancet Neurology 14, 1037–1053. https://doi.org/10.1016/S1474-4422(15)00093-9 (2015).Article
PubMed
Google Scholar
Lee, G., Nho, Ok., Kang, B., Sohn, Ok. A. & Kim, D. Predicting Alzheimer’s disease development using multi-modal deep studying strategy. Sci. Rep. 9, 1952. https://doi.org/10.1038/s41598-018-37769-z (2019).Article
ADS
CAS
PubMed
PubMed Central
Google Scholar
Spasov, S., Passamonti, L., Duggento, A., Liò, P. & Toschi, N. A parameter-efficient deep studying strategy to foretell conversion from gentle cognitive impairment to Alzheimer’s disease. Neuroimage 189, 276–287. https://doi.org/10.1016/j.neuroimage.2019.01.031 (2019).Article
PubMed
Google Scholar
Marek, Ok. et al. The Parkinson’s development markers initiative (PPMI)—Establishing a PD biomarker cohort. Ann. Clin. Transl. Neurol. 5, 1460–1477. https://doi.org/10.1002/acn3.644 (2018).Article
CAS
PubMed
PubMed Central
Google Scholar
Nasreddine, Z. S. et al. The montreal cognitive evaluation, MoCA: A quick screening software for gentle cognitive impairment. J. Am. Geriatr. Soc. https://doi.org/10.1111/j.1532-5415.2005.53221.x (2005).Article
PubMed
Google Scholar
Klein, A. & Tourville, J. 101 Labeled mind pictures and a constant human cortical labeling protocol. Front. Neurosci. 6, 171. https://doi.org/10.3389/fnins.2012.00171 (2012).Article
PubMed
PubMed Central
Google Scholar
Dale, A. M., Fischl, B. & Sereno, M. I. Cortical surface-based evaluation. I. Segmentation and floor reconstruction. Neuroimage 9, 179–194. https://doi.org/10.1006/nimg.1998.0395 (1999).Article
CAS
PubMed
Google Scholar
Fischl, B. FreeSurfer. Neuroimage 62, 774–781. https://doi.org/10.1016/j.neuroimage.2012.01.021 (2012).Article
PubMed
Google Scholar
Fischl, B. & Dale, A. M. Measuring the thickness of the human cerebral cortex from magnetic resonance pictures. Proc. Natl. Acad. Sci. U.S.A. 97, 11050–11055. https://doi.org/10.1073/pnas.200033797 (2000).Article
ADS
CAS
PubMed
PubMed Central
Google Scholar
Fischl, B., Sereno, M. I. & Dale, A. M. Cortical surface-based evaluation: II: Inflation, flattening, and a surface-based coordinate system. Neuroimage 9, 195–207. https://doi.org/10.1006/nimg.1998.0396 (1999).Article
CAS
PubMed
Google Scholar
Fischl, B. et al. Whole mind segmentation: Automated labeling of neuroanatomical constructions in the human mind. Neuron 33, 341–355. https://doi.org/10.1016/S0896-6273(02)00569-X (2002).Article
CAS
PubMed
Google Scholar
Iglesias, J. E. et al. A computational atlas of the hippocampal formation using ex vivo, ultra-high decision MRI: Application to adaptive segmentation of in vivo MRI. Neuroimage 115, 117–137. https://doi.org/10.1016/j.neuroimage.2015.04.042 (2015).Article
PubMed
Google Scholar
Iglesias, J. E. et al. A probabilistic atlas of the human thalamic nuclei combining ex vivo MRI and histology. Neuroimage 183, 314–326. https://doi.org/10.1016/j.neuroimage.2018.08.012 (2018).Article
PubMed
Google Scholar
Saygin, Z. M. et al. High-resolution magnetic resonance imaging reveals nuclei of the human amygdala: Manual segmentation to automated atlas. Neuroimage 155, 370–382. https://doi.org/10.1016/j.neuroimage.2017.04.046 (2017).Article
CAS
PubMed
Google Scholar
Aarsland, D. et al. Cognitive decline in Parkinson disease. Nat. Rev. Neurol. 13, 217–231. https://doi.org/10.1038/nrneurol.2017.27 (2017).Article
PubMed
PubMed Central
Google Scholar
Robnik-Sikonja, M., & Kononenko, I. An adaptation of aid for attribute estimation in regression. In ICML’97 proceedings. (1997).Kira, Ok. & Rendell, L. A. The characteristic choice downside: conventional strategies and a brand new algorithm. In AAAI-92 proceedings (1992).
https://www.nature.com/articles/s41598-023-37644-6
